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Nareh V. Marukian, BA; Rong-Hua Hu, BS; Brittany G. Craiglow, MD; Leonard M. Milstone, MD; Jing Zhou, PhD;
Amy Theos, MD; Hande Kaymakcalan, MD; Deniz A. Akkaya, MD; Jouni J. Uitto, MD, PhD;
Hassan Vahidnezhad, MSc; Leila Youssefian, MSc; Susan J. Bayliss, MD; Amy S. Paller, MD;
Lynn M. Boyden, PhD; Keith A. Choate, MD, PhD

IMPORTANCE Bathing suit ichthyosis (BSI) is a rare congenital disorder of keratinization
characterized by restriction of scale to sites of relatively higher temperature such as the
trunk, with cooler areas remaining unaffected. Fewer than 40 cases have been reported in
the literature. Bathing suit ichthyosis is caused by recessive, temperature-sensitive mutations
in the transglutaminase-1 gene (TGM1). Clear genotype-phenotype correlations have been
difficult to establish because several of the same TGM1 mutations have been reported in BSI
and other forms of congenital ichthyosis. We identify novel and recurrent mutations in 16
participants with BSI.
OBJECTIVE To expand the genotypic spectrum of BSI, identifying novel TGM1 mutations in

patients with BSI, and to use BSI genotypes to draw inferences about the temperature
sensitivity of TGM1 mutations.
DESIGN, SETTING, AND PARTICIPANTS A total of 16 participants with BSI from 13 kindreds were
identified from 6 academic medical centers. A detailed clinical history was obtained from
each participant, including phenotypic presentation at birth and disease course. Each
participant underwent targeted sequencing of TGM1.
MAIN OUTCOMES AND MEASURES Phenotypic and genotypic characteristics in these patients

from birth onward.
RESULTS Of the 16 participants, 7 were male, and 9 were female (mean age, 12.6 years; range,
1-39 years). We found 1 novel TGM1 indel mutation (Ile469_Cys471delinsMetLeu) and 8 TGM1
missense mutations that to our knowledge have not been previously reported in BSI: 5 have
been previously described in non–temperature-sensitive forms of congenital ichthyosis
(Arg143Cys, Gly218Ser, Gly278Arg, Arg286Gln, and Ser358Arg), and 3 (Tyr374Cys,
Phe495Leu, and Ser772Arg) are novel mutations. Three probands were homozygous for
Arg264Trp, Arg286Gln, or Arg315Leu, indicating that these mutations are temperature
sensitive. Seven of 10 probands with a compound heterozygous TGM1 genotype had a
mutation at either arginine 307 or 315, providing evidence that mutations at these sites are
temperature sensitive and highlighting the importance of these residues in the pathogenesis
of BSI.
CONCLUSIONS AND RELEVANCE Our findings expand the genotypic spectrum of BSI and the
understanding of temperature sensitivity of TGM1 mutations. Increased awareness of
temperature-sensitive TGM1 genotypes should aid in genetic counseling and provide insights
into the pathophysiology of TGM1 ichthyoses, transglutaminase-1 enzymatic activity, and
potential therapeutic approaches.
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A

utosomal recessive congenital ichthyosis (ARCI) is a
heterogeneous group of disorders of keratinization linked
by the common finding of generalized hyperkeratosis and
often accompanied by erythroderma. ARCI is rare, with an incidence of approximately 1 in 200 000 births.1
The major phenotypic subtypes of ARCI include lamellar
ichthyosis (LI), congenital ichthyosiform erythroderma, and harlequin ichthyosis. While ARCI is genetically heterogeneous, with
at least 9 different genes causative for the most common forms,2
approximately 30% of the heritability of ARCI is explained by
mutations in the TGM1 gene,3 which encodes transglutaminase-1
(TGase-1), an enzyme involved in the formation of the cornified
envelope.4
While mutations in TGM1 most commonly cause a spectrum
of LI and congenital ichthyosiform erythroderma phenotypes of
varying severity, they also underlie bathing suit ichthyosis (BSI),
a very rare form of ARCI with fewer than 40 reported cases characterized by lamellar scaling restricted primarily to the trunk, neck
and scalp. Affected infants are typically born as collodion babies
and develop more localized scaling after shedding of the membrane. Bathing suit ichthyosis is due to the temperature sensitivity of certain TGM1 mutations.5 Clear genotype-phenotype correlations have been difficult to establish owing to the rarity of BSI
and because many of the BSI mutations have also been reported
in individuals with more generalized forms of ARCI. The present
study of 16 individuals from 13 kindreds expands the spectrum
of TGM1 mutations known to occur in patients with BSI and the
understanding of mutations related to temperature sensitivity.

Methods
Participants and Samples
The study was approved by the Yale human investigation committee, consistent with the Declaration of Helsinki guidelines,
and written informed consent was provided by all 16 participants
(7 male and 9 female; mean age, 12.6 years; range, 1-39 years) or
their parents. A detailed clinical history was obtained from each
participant, including phenotypic presentation at birth and evolution of disease when available. Self-reporting of ethnicity was
obtained to evaluate for a founder effect. Saliva samples were obtained from all participants for genetic analysis.

Genetic Analysis
Genetic analysis was performed on DNA isolated from the saliva
of participants and both parents, if available. The DNA was extracted using standard procedures. Samples were analyzed in
1 of 2 ways: (1) they were screened for mutations in 11 genes
(ABCA12, ALOXE3, ALOX12B, CYP4F22, NIPAL4, PNPLA1,
SPINK5, TGM1, KRT1, KRT2E, and KRT10) via multiplex polymerase chain reaction and next-generation sequencing; or (2) the
coding exons of TGM1 were amplified using polymerase chain
reaction and subsequently examined via Sanger sequencing.
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Key Points
Question Can targeted sequencing of 13 kindreds with bathing
suit ichthyosis (BSI) reveal novel mutations and provide evidence
of temperature sensitivity of specific TGM1 mutations?
Findings We report 1 novel TGM1 indel mutation
(Ile469_Cys471delinsMetLeu) and 8 TGM1 missense mutations
that have not been previously found in BSI: 5 have been previously
described in non–temperature-sensitive forms of congenital
ichthyosis, and 3 are novel mutations. We also provide evidence
for temperature sensitivity of Arg264Trp, Arg286Gln, Arg307Gly,
Arg315Leu, Arg315His, and Phe495Leu, highlighting the
importance of these residues in the pathogenesis of BSI.
Meaning Our findings expand the genotypic spectrum of BSI.

vided in Figure 1 (patients 8 and 15), and the locations of the mutations relative to TGM1 protein domains are shown in Figure 2.

Homozygous TGM1 Mutations and Temperature Sensitivity:
Arg264Trp, Arg286Gln, and Arg315Leu TGM1 Mutations in BSI
Patient 1 was the child of first cousins. He was born with a collodion membrane and later developed large brown scales on the
back, chest, and groin, with sparing of the face and extremities.
He was homozygous for a TGM1 Arg286Gln missense mutation,
which has been previously reported in a compound heterozygous
state with Gly278Arg in LI6 (and also found in patient 9), but to
our knowledge has not been previously reported in BSI.
Patients 2 and 3 were siblings and the children of second
cousins. Both were born with normal skin at birth and no collodion membrane and went on to develop platelike scale restricted
to the neck, scalp, trunk, and flexural areas of the upper extremities. Nonscarring alopecia was present in both patients, and both
siblings were homozygous for a TGM1 Arg264Trp missense mutation, which has previously been found in a compound heterozygous state in a patient with BSI.5 It was also found in a heterozygous state in patient 4, a female with TGM1 mutations
Arg264Trp and Gly278Arg. The Gly278Arg mutation has been
previously described in both LI6 and in self-healing ichthyosis,
a rare form of ARCI characterized by the presence of a collodion
membrane at birth with spontaneous healing of the phenotype
within the first few weeks.7,8
Patients 5 and 6 were African American siblings with
no known consanguinity in the family. Both were born
with a collodion membrane and later developed platelike scale
restricted to the scalp and trunk. They were both homozygous for a TGM1 Arg315Leu mutation, which has been reported in a cohort of 8 South African patients with BSI.9,10
The observation of homozygous mutations in these 5
patients with BSI provides evidence that these TGM1 mutations (Arg264Trp, Arg286Gln, and Arg315Leu) occurred
with temperature sensitivity. All fall within the catalytic
core of the transglutaminase-1 enzyme (Figure 2).

Results

Temperature-Sensitive Substitutions at R315 TGM1:
Common Compound Heterozygous Mutations in BSI

The BSI phenotypes and TGM1 genotypes of each participant are
summarized in the Table. Representative photographs are pro-

Patients 7 and 8 were siblings. Both were born with a collodion membrane and were noted to have thickened, fragile skin

JAMA Dermatology June 2017 Volume 153, Number 6 (Reprinted)

© 2017 American Medical Association. All rights reserved.

Downloaded From: http://jamanetwork.com/ by a Thomas Jefferson University User on 07/06/2017

jamadermatology.com

Expanding the Genotypic Spectrum of Bathing Suit Ichthyosis

Original Investigation Research

Table. TGM1 Mutations in Patients With BSI
Patient
No./Sex/Age, y

Study Presentationa
Ethnicity

Presentation at Birth

Scalp

Neck

Trunk

Extremities

Zygosity

Mutation in
Coding DNA

Protein Effectb

1/M/4

Middle
Eastern

Collodion membrane

o

x

x

o

HOM

c.857 G>A

Arg286Glnc

2/F/37

Middle
Eastern

Normal skin at birth,
no collodion membrane

x

x

x

x (Flexural)

HOM

c.790 C>T

Arg264Trp

3/F/32

Middle
Eastern

Normal skin at birth,
no collodion membrane

x

x

x

x (Flexural)

HOM

c.790 C>T

Arg264Trp

4/F/39

White

Collodion membrane

x

x

x

o

HET

c.790 C>T
c.832G>A

Arg264Trp
Gly278Argc

5/M/4

African
American

Collodion membrane,
thickened skin

x

o

x

o

HOM

c.944 G>T

Arg315Leu

6/F/9

African
American

Collodion membrane,
thickened skin

x

o

x

o

HOM

c.944 G>T

Arg315Leu

7/F/11

African
American

Collodion membrane,
thickened, fragile skin

x

x

x

x (Very mild)

HET

c.944 G>T
c.2316 C>A

Arg315Leu
Ser772Argc,d

8/M/8

African
American

Collodion membrane,
thickened, fragile skin

x

x

x

x (Mild)

HET

c.944 G>T
c.2316 C>A

Arg315Leu
Ser772Argc,d

9/M/8

Turkish

Collodion membrane,
ectropion as a neonate

x

x

x

x (Flexural)

HET

c.944 G>A
c.832G>A

Arg315His
Gly278Argc

10/M/1

White

Collodion membrane,
thickened skin

x

o

x

o

HET

c.944 G>A
c.876 + 2 t > C

Arg315His
splice site

11/F/4

Irish

Collodion membrane

x

x

x

o

HET

c.919 C>G
c.877-2 A>G

Arg307Gly
splice site

12/M/21

Hispanic

Collodion membrane

x

x

x

o

HET

c.919 C>G
c.652 G>A

Arg307Gly
Gly218Serc

13/F/9

Northern
European

Collodion membrane

x

x

x

o

HET

c.919 C>G
c.1074 C>G

Arg307Gly
Ser358Argc

14/F/1

White

Collodion membrane,
thickened, fragile skin

x

o

x

o

HET

c.919 C>G
c.1121 A>G

Arg307Gly
Tyr374Cysc,d

15/M/13

White

Collodion membrane

x

x

x

x (Flexural)

HET

c.427 C>T
c.1483 t > C

Arg143Cysc
Phe495Leuc,d

16/F/1

White

Collodion membrane

x

x

x

o

HET

c.872 G>A
c.1407_
1416del10ins
GCTCTGT

Gly291Asp
I469_C471
delinsMLc,d

Abbreviations: BSI, bathing suit ichthyosis; HET, heterozygous;
HOM, homozygous; o, absence of scaling; x, presence of scaling.
a

No patient had facial involvement.

b

Boldface indicates temperature-sensitive mutations.

at birth. They developed dark platelike scaling, most prominent on the back, chest, and neck. Both were compound heterozygous for TGM1 Arg315Leu, a temperature-sensitive mutation, and Ser772Arg, a novel mutation falling within the
β-barrel 2 domain (Figure 2).
Patient 9 was born with a collodion membrane and ectropion. At the time of the study he had brown platelike scales
most prominent on the neck, scalp, and trunk, with sparing
of the face and the extremities. He also exhibited attentiondeficit/hyperactivity disorder and developmental delay. He was
compound heterozygous for TGM1 (Arg315His and Gly278Arg).
While both mutations fall within the catalytic core, Arg315His
affects the same residue as Arg315Leu (found in patients 5-8)
and has been commonly reported in patients with BSI.5,11 The
Gly278Arg mutation was also found in patient 4.
Patient 10 was born with a collodion membrane and later
developed scaling restricted to the scalp and trunk. He had
TGM1 mutations Arg315His and c.876 + 2 T > C, a mutation
within the donor splice site of exon 5 previously described in
generalized ARCI.12
The observation of a missense mutation at R315 in 6 of the
16 participants highlights the prevalence of substitutions at this
jamadermatology.com

c

Mutations not previously found in BSI.

d

Novel mutations.

site in BSI and contributes to evidence that such mutations are
temperature sensitive.

Temperature-Sensitive TGM1 Arg307Gly:
A Common BSI Mutation
Patient 11 was born with a collodion membrane that peeled at a
few weeks of age, and she developed thick dark scale on the scalp,
neck, axillae, and groin by age 1 year. She was compound heterozygous for TGM1 Arg307Gly, which has been commonly described
in BSI,5,11 and c.877-2 A>G, a mutation within the acceptor splice
site of exon 6, which has previously been found in BSI in conjunction with Arg307Gly (as in patient 11) as well as with Arg264Trp
and Arg315His in the present cohort.5,11
Patient 12 was born with a collodion membrane. At the time
of the study he had brown platelike scales most prominent on
the neck, scalp, axillae, and trunk. He was compound heterozygous for TGM1 Gly218Ser and Arg307Gly. The Gly218Ser mutation has been previously reported in an individual with LI
with a collodion membrane at birth and later development of
thick scales and ectropion.13
Patient 13 was born with a collodion membrane. At the time
of the study she had thick dark scale restricted to the neck,
(Reprinted) JAMA Dermatology June 2017 Volume 153, Number 6
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Figure 1. Clinical Features of Bathing Suit Ichthyosis (BSI)
A Patient 8

B

Patient 15

Representative photographs of the
BSI phenotype, notable for platelike
scaling of the trunk and back, with
sparing of the extremities and
buttocks.

scalp, and trunk. She had TGM1 mutations Arg307Gly and
Ser358Arg. The Ser358Arg mutation has been previously reported in 2 siblings with LI who were born with collodion membranes and later developed generalized scaling with facial and
palmoplantar involvement.14,15
Patient 14 was born with a collodion membrane and later
developed scaling restricted to the trunk and scalp. She had
TGM1 mutations Arg307Gly and Tyr374Cys. The Tyr374Cys
mutation was within the catalytic domain and to our knowledge has not been described previously.
The observation of the Arg307Gly mutation in 4 out of
the 16 study participants contributes to evidence that
Arg307Gly is relatively common in BSI and is a temperaturesensitive mutation.

TGM1 Phe495Leu: A Temperature-Sensitive Mutation
Patient 15 was born with a collodion membrane. At the time
of the study he had thick scale restricted to the neck, scalp,
and trunk, as well as flexural involvement of the extremities. He has TGM1 mutations Arg143Cys and Phe495Leu.
Homozygosity for the Arg143Cys mutation has been previously described in 2 patients with LI.13 We therefore pre540

sume that Phe495Leu, which is novel, is the temperaturesensitive mutation in patient 15.

TGM1 Ile469_Cys471delinsMetLeu:
A Novel Mutation in the Catalytic Core
Patient 16 was born with a collodion membrane. At the time
of the study she had scale restricted to the neck, scalp, and
trunk. She had TGM1 mutations Gly291Asp and
Ile469_Cys471delinsMetLeu. The Gly291Asp mutation was
previously described in a compound heterozygous state in a
patient with BSI16 as well as in a patient with generalized
ARCI. 17 The TGM1 Ile469_Cys471delinsMetLeu is a novel
in-frame indel mutation that affects the catalytic core.

Discussion
Bathing suit ichthyosis is a rare ARCI phenotype characterized by presentation at birth with a collodion membrane followed by clinical improvement of ichthyosis on the face and
extremities during the first few weeks of life. The resulting phenotype of scaling restricted to the trunk, neck, and scalp is a
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Tranglutaminase-1
Domains

N

III

IV

V

VI

VII

β-Sandwich

VIII

IX

Catalytic core

X

Ser772Arga,b

Ser358Arga
Tyr374Cysa,b

II

Arg307Gly
Arg315His, Arg315Leu

I

Arg264Trp
Gly278Arga
Arg286Glna
Gly291Asp

5′

Gly218Sera

TGM1
Exons I-XV

Arg143Cysa

c.876+2 T>C
c.877–2 A>G

IIe469_Cys471delinsMetLeua,b
Phe495Leua,b

Figure 2. Protein Schematic of TGM1 Mutations Found in Bathing Suit Ichthyosis (BSI)

XI

β-Barrel 1

XII

β-Barrel 2

XIII

XIV

XV

3′

C

Thirteen mutations are located in the catalytic core, 2 in the β-sandwich
domain, and 1 in the β-barrel 2 domain. Nine mutations lead to substitution of
charged residues. Temperature-sensitive mutations are shown in red.

a

Mutations not previously described in BSI.

b

Novel mutations.

distinguishing feature of BSI and can be differentiated from somatic mosaicism by the lack of a distribution pattern along the
Blaschko lines.
Prior to the present report, 21 missense mutations had been
reported in patients with BSI. Of these, 9 had been reported
exclusively in patients with BSI, while 12 had been observed
in both BSI and generalized ARCI.18 Both truncating mutations (nonsense, splice site, and frameshift) and missense mutations in TGM1 have been found in individuals with
BSI.5,9,11,16,18,19 However, while homozygosity or compound heterozygosity for truncating mutations has been observed in generalized forms of ARCI,14,20,21 to our knowledge, such a genotype has never been observed in BSI. This is consistent with
the hypothesis that near or total loss of TGase-1 function causes
generalized forms of ARCI, while genotypes that include a missense mutation resulting in a partially active, temperaturesensitive TGase-1 result in the more limited BSI phenotype.
In 2006, Oji et al5 investigated TGase-1 enzymatic activity in
BSI tissue, assessing uptake of biotinylated cadaverine into cornified envelopes, and found that areas of healthy skin in patients
with BSI show nearly normal TGase-1 activity, while affected areas
display clearly reduced and abnormal activity. Furthermore, digital thermal imaging showed close association between skin temperature and the degree of scaling in patients with BSI, with
warmer body sites exhibiting greater scaling. Functional TGase-1
testing of normal-appearing skin of a patient with BSI and homozygous for the missense mutation Tyr276Asn showed clear temperature sensitivity, with reduction in enzyme activity at 37°C
compared with 25°C. This may explain the increased degree of
scaling at sites of relatively higher temperature, such as the trunk.5
In addition to the TGM1 mutation Tyr276Asn, several other
mutations have been previously presumed to be temperature

sensitive based on their presence in a homozygous state in individuals with BSI, including TGM1 mutations Ile304Phe,
A rg 3 0 7 G l y, A rg 3 1 5 L e u , A rg 3 1 5 H i s , Va l 3 83 Me t , a n d
Arg687His.5,9-11,16,18,22
In the present study, we report phenotypic and genotypic
data from 16 patients with BSI, the largest known cohort published to date. Aside from a pair of siblings who had normal skin
at birth with no collodion membrane (patients 2 and 3), the phenotypes were consistent with prior descriptions of BSI. Of note,
while collodion membrane is found in the majority of ARCI due
to TGM1 mutation, this finding is not universal.23 We identified
a total of 16 unique mutations in our cohort, including 13 missense
mutations, 2 splice-site mutations, and 1 indel mutation. Eight
of the missense mutations have not to our knowledge been previously reported for BSI; of these, 5 have been previously described in generalized ARCI (Arg143Cys, Gly218Ser, Gly278Arg,
Arg286Gln, and Ser358Arg), while 3 (Tyr374Cys, Phe495Leu, and
Ser772Arg) are novel mutations. The indel mutation TGM1
I469_C471delinsML is also novel.
Transglutaminase-1 consists of 3 domains: an N-terminal
β-sandwich domain, a catalytic core domain, and 2 Cterminal β-barrel domains.24 Most BSI mutations have been
located in exons 5 and 6 of TGM1, encoding the N-terminal portion of the catalytic core domain.5 Of the 13 unique missense
mutations reported in the present study, only 2 were within
the β-sandwich domain (Arg143Cys and Gly218Ser) and 1 was
within the β-barrel 2 domain (Ser772Arg). In stark contrast, 10
were within the catalytic core (Arg264Trp, Gly278Arg,
Arg286Gln, Gly291Asp, Arg307Gly, Arg315His, Arg315Leu,
Ser358Arg, Tyr374Cys, and Phe495Leu), including all 3 of the
mutations in our homozygous participants (Figure 2). All of our
participants had at least 1 mutation within the catalytic core,
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and catalytic core mutations represent 88% of the mutations
in our unrelated probands (23 of 26 alleles). Given that the catalytic core is only 38% of the total protein, our findings underscore a striking clustering of BSI mutations in this domain.
Based on our observation of patients with BSI homozygous
for TGM1 mutations Arg264Trp, Arg286Gln, and Arg315Leu, we
conclude that these mutations are temperature sensitive. Furthermore, the recurrence of mutations affecting R307 and R315
in our cohort—which among unrelated probands are present in
one-third of homozygotes and seven-tenths of compound heterozygotes, comprising 35% of the mutations (9 of 26 total
alleles)—bolsters prior evidence that these mutations are common in BSI (also reported by Bourrat et al11) and that they are temperature sensitive. Finally, we hypothesize that the novel mutation Phe495Leu is also temperature sensitive, given that the
TGM1 genotype of patient 15 included this mutation along with
Arg143Cys. The Arg143Cys mutation is presumably not temperature sensitive, given that patients homozygous for Arg143Cys
have been described as exhibiting generalized LI.13
Though our findings provide evidence for temperature sensitivity of TGM1 mutations, clear genotype-phenotype correlations have been difficult to establish because several TGM1 mutations have been reported in both BSI and generalized ARCI. For
example, homozygosity for Arg315Leu has been found in a pair
of twins who were described as having LI and whose phenotype
at age 2 months included thick platelike scaling on the trunk and
extremities but sparing the face.25 Another patient described as
having characteristic phenotypic findings of LI was found to be
compound heterozygous for TGM1 mutations, including
Arg286Gln,6 which we describe here as temperature sensitive.
The presence of these mutations in both BSI and generalized ARCI may represent evolution of the phenotype; patients with BSI can present with more generalized scaling ear-
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lier in life and then manifest bathing-suit distribution later in
childhood. Thus, phenotypic characterization within the first
few months of life may lead to misclassification. This dynamic nature of BSI highlights the importance of continued follow-up of patients with presumed temperature-sensitive mutations, including phenotypic reevaluation at multiple ages.
Additional environmental or genetic factors that may determine the level of enzyme activity and response to temperature in patients with TGM1 mutations remain unclear.
Patients with BSI typically respond well to agents that improve barrier function and promote desquamation, including
keratolytics and topical or systemic retinoids. Topical tazarotene led to substantial improvement in 2 of the present study
participants.

Limitations
Since BSI is such a rare disorder, we were unable to recruit a
large enough cohort to identify additional genetic modifiers
that may contribute to temperature sensitivity in BSI due to
TGM1 mutations.

Conclusions
Our findings expand the genotypic spectrum of BSI and provide
evidence supporting the temperature sensitivity of specific TGM1
mutations (Arg264Trp, Arg286Gln, Arg307Gly, Arg315Leu,
Arg315His, and Phe495Leu), which are clustered in the catalytic
core. Although patients respond well to topical and systemic
therapies, further research into the pathogenesis of BSI could lead
to the development of novel therapeutic approaches targeting
enzymatic stability and consideration of environmental modifications that might modify disease severity.
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NOTABLE NOTES

Tinea in the Time Before Modern Antifungal Agents
Helena Jenkinson, BS; Beau DiCicco, MD

Modernity enjoys a broad and effective arsenal against superficial mycoses. However, the history of social stigma attached to dermatophyte
infections, their unusual and often harmful treatments, and the controversial public health efforts designed to limit their spread before the discovery of safe and efficacious antifungal agents is worthy of reflection.
Tinea capitis and corporis were major public health challenges prior
to the introduction of oral griseofulvin in 1958. Crowded classrooms were
an efficient venue for transmission. In an attempt to mitigate exposure to
their classmates, students infected with tinea were excluded from schooling until cured; they fell behind in their education, prompting the creation of special schools where they were able to continue their lessons and
receive treatment while being isolated from uninfected children.1
Therapies for tinea ranged from relatively harmless to downright toxic
and included copper coins soaked in vinegar, writing ink, creosote, mercury, carbolic acid, and cantharides. However, that fungal infections of
the scalp represented a greater challenge for treatment vs those of the
body.2 Epilation for treatment of tinea capitis was a common practice,
with the rationale being that it simultaneously removed the nidus of infection and increased the penetrance of topical therapies.1,2
In 1904 French dermatologist Raymond Sabouraud popularized the
use of radiographic epilation for treatment of tinea capitis, which offered greater efficacy, reduced cost, and less discomfort than the chemical and mechanical methods of epilation available at the time but required having patients sit still for periods as long as 40 minutes while
exposed to multiple overlapping fields of radiation.1

jamadermatology.com

Despite concerns regarding the long-term effects of directing radiation toward children’s heads for extended periods of time, radiographic
epilation remained a mainstay of treatment until the arrival of griseofulvin in 1958.1,3 Numerous reports have described adverse long-term
effects associated with radiation therapy for tinea capitis, including permanent hair loss and cancers of the skin, brain, and thyroid.3
Before the discovery of modern antifungal agents, simple dermatophyte infections represented major barriers to education and social acceptance. Patients often underwent treatments more physically harmful than the diseases themselves. The history of tinea corporis and capitis
highlights the cultural significance of skin disease throughout the ages
and reminds us of the value of the relatively safe and efficacious antimycotic therapeutics available today.
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